跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,677 条关于
“Femasys Inc”
全部
41,677
临床试验
11,981
药物
1,598
机构
6,168
资讯
21,930
2年前
Femasys Receives FDA Clearance for FemChec Fallopian Tube Diagnostic
10个月前
Femasys Secures FDA Approval to Advance Final Phase of FemBloc Pivotal Trial for Non-Surgical Permanent Birth Control
去年
Femasys Raises $4.5 Million to Advance Women's Health Technologies Including FemBloc Birth Control
去年
Femasys Receives World's First Regulatory Approval for Non-Surgical Permanent Birth Control System in Europe
去年
Femasys Partners with Carolinas Fertility Institute to Expand FemaSeed Access Across North Carolina Network
去年
FemBloc Non-Surgical Birth Control Shows 100% Effectiveness in Clinical Trials with Five-Year Safety Data
上个月
Femasys Announces FDA Approval of Modular PMA Pathway for FemBloc Non-Surgical Permanent Birth Control
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
第 1 页,共 2193 页
上一页
下一页